| abstract |
In the 1-aryl-3-iminopyrazoles of formula (I) of the present invention, R31 is hydrogen, -CN-, -NO2-, -NO-, -SH-, alkylthio, heterocyclic or optionally substituted amino, alkyl. -, cycloalkyl, cycloalkylalkyl, naphthyl or phenyl, or -P (O) (OR8) (OR9), -NH-CO-NH-N = CR8R9, -NH-CS-NH-N = CR8- One of R9, -NH-CO-NR8R9, -NH-CS-NR8R9, -NH-CO-OR8, -NH-CS-OR8, -NH-CO-NH-NH2; R32 is optionally substituted alkyl, cycloalkyl, cycloalkylalkyl, phenyl or heterocyclic; R33 is a single electron pair or an oxygen or sulfur atom, an alkyl group, or R31 and R33 together form an alkylene group, wherein one or two of the carbon atoms are optionally substituted with a heteroatom; R8 and R9 are hydrogen or optionally substituted alkyl, R4 is R11 or -S (O) nR11, R11 is alkyl, cycloalkyl or cycloalkylalkyl optionally substituted by halogen, n is 0, 1 or 2; R5 is hydrogen or halogen, cyano, -S (O) nR8, -OR8, -NR8R9, -N (R8) CON (R9) (R8), azido or -N = C (R10) (OR9), R10 is the same as R8 or benzyl or optionally substituted phenyl; Z is nitrogen or = C-R16; and R12-R16 are hydrogen or halogen, R8, -OR8, -SF5, -S (O) nR8, cyano, nitro, formyl, -C (O) R8 or -COOR8. HE |